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Calcium-activated anion secretion is expected to ameliorate cystic fibrosis, a genetic
disease that carries an anion secretory defect in exocrine tissues. Human patients
and animal models of the disease that present a mild intestinal phenotype have
been postulated to bear a compensatory calcium-activated anion secretion in the
intestine. TMEM16A is calcium-activated anion channel whose presence in the intestinal
epithelium is contradictory. We aim to test the functional expression of TMEM16A
using animal models with Cftr and/or Tmem16a intestinal silencing. Expression of
TMEM16A was studied in a wild type and intestinal Tmem16a knockout mice by
mRNA-seq, mass-spectrometry, q-PCR, Western blotting and immunolocalization.
Calcium-activated anion secretion was recorded in the ileum and proximal colon of these
animals including intestinal Cftr knockout and double mutants with dual Tmem16a and
Cftr intestinal ablation. Mucus homeostasis was studied by immune-analysis of Mucin-2
(Muc2) and survival curves were recorded. Tmem16a transcript was found in intestine.
Nevertheless, protein was barely detected in colon samples. Electrophysiological
measurements demonstrated that the intestinal deletion of Tmem16a did not change
calcium-activated anion secretion induced by carbachol or ATP in ileum and proximal
colon. Muc2 architecture was not altered by Tmem16a silencing as was observed
when Cftr was deleted from mouse intestine. Tmem16a silencing neither affected animal
survival nor modified the lethality observed in the intestinal Cftr-null mouse. Our results
demonstrate that TMEM16A function in the murine intestine is not related to electrogenic
calcium-activated anion transport and does not affect mucus homeostasis and survival
of animals.
Keywords: TMEM16A, cystic fibrosis transmembrane conductance regulator, epithelial transport, colon,
intestinal mucus
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INTRODUCTION
Electrogenic intestinal anion secretion relies on the concerted
action of apical and basolateral membrane proteins. Chloride
and bicarbonate accumulate in the intracellular milieu by
the activity of basolateral co-transporters and exchangers that
provide the required driving force for anion secretion at the apical
membrane. Apical exit of anions has two components in many
epithelial cells: one component depends on cAMP whereas the
other one is controlled by Ca2+. While the cAMP-dependent
secretion is occurring through CFTR, there is still controversy
about the existence and role of a non-CFTR Ca2+-activated
chloride secretion in the intestine.
Extensive information about Ca2+-activated anion secretion
has been gained through studies of cystic fibrosis. Cystic fibrosis
is the most common human genetic disease; anion secretion is
severely decreased due to mutations in the Cftr gene affecting
mainly airway function, but an important number of patients
are also affected by intestinal problems with mucus attachment
and obstruction (Gustafsson et al., 2012; De Lisle and Borowitz,
2013). In some patients the existence of Ca2+-dependent
anion secretion correlates with less severe intestinal symptoms
(Bronsveld et al., 2000). Surprisingly, the CF mouse is not
affected by muco-obstructive airway disease mostly due to the
existence of an active Ca+2-activated chloride conductance
(Grubb and Boucher, 1999), known to correspond to the
TMEM16A protein (Ousingsawat et al., 2009; Rock et al.,
2009; Gianotti et al., 2016). Nevertheless, CF-mice are severely
affected by intestinal obstructive disease and importantly, the
survival of the animals is favored by the existence of intestinal
Ca+2-activated chloride secretion, that might correspond to a
modifier gene of intestinal CF (Rozmahel et al., 1996; Wilschanski
et al., 1996; Bleich et al., 2007).
Experiments in the Tmem16a−/− mouse pups have shown
that there is a reduction in the intestinal Ca2+-dependent
chloride secretion (Ousingsawat et al., 2009). Similar results
were observed when Tmem16a was specifically silenced from
the intestinal epithelium of adult mice (Schreiber et al., 2015)
and, more recently, calcium-activated chloride secretion has been
reported to be decreased concomitantly to TMEM16A expression
in mouse colon (Rottgen et al., 2018). Nevertheless, we and others
have determined that both cAMP and Ca+2-activated chloride
secretion are occurring via CFTR exclusively in both human
and mouse intestine (Seidler et al., 1997; Mall et al., 2000a,b;
Zdebik et al., 2004; Bijvelds et al., 2009; Flores et al., 2009; Philp
et al., 2018). Intestinal expression of the TMEM16A protein
is also a controversial matter, as expression has been reported
across the colon epithelium in different portions of the organ
(Ousingsawat et al., 2011; Faria et al., 2014; Schreiber et al., 2015).
Finally, subcellular expression has been shown to correspond at
apical and basolateral membrane locations of intestinal epithelial
cells (Yu et al., 2010; He et al., 2011; Ousingsawat et al., 2011;
Benedetto et al., 2017; Rottgen et al., 2018).
To test if TMEM16A is expressed and correspond to an
important player in Ca2+-dependent chloride secretion in the
intestine we used the Tmem16afl/fl mouse mated with the
Villincre/− mouse to generate an intestinal Tmem16a knock-out
mouse line and study its function. To evaluate if Tmem16
corresponds to a modifier gene of intestinal CF disease
we crossed the intestinal Tmem16a knock-out animal with
the Cftrfl/fl mouse to generate an intestinal double mutant
the Cftrfl/fl/Tmem16afl/fl/Villincre/− mouse. We observed that
lethality of the Cftr−/−/Villincre/− mouse was not altered by the
concomitant deletion of Tmem16a in the intestinal epithelium.
We also evaluated short-circuit currents in ileum and colon
samples and found that there were no changes in the magnitude
of the currents of the Tmem16a−/−/Villincre/− intestine when
compared to controls. Mucus homeostasis was also unaltered
in the Tmem16a−/−/Villincre/−, but severely affected in the




All chemicals were from Sigma-Aldrich unless stated.
Animals and Tamoxifen Treatment
The Villin-Cre (Villincre/−) mouse was obtained from The
Jackson Laboratories. The Cftr conditional null mouse (Cftrfl/fl)
(Hodges et al., 2008) and Tmem16a mouse (Tmem16afl/fl) (Faria
et al., 2014) were obtained from their respective laboratories
of origin. These animals were housed and mated at CECs
animal facility and, male and female animals were used. All
experimental procedures were approved by the Centro de
Estudios Científicos (CECs) Institutional Animal Care and Use
Committee. The Ubc-CreERT2 mouse was obtained from The
Jackson Laboratories and the Tmem16afl/fl from its laboratory
of origin. The mice colonies were maintained in the IRCCS
San Martino–IST Animal Facility (Genoa, Italy). Mice, aged
55–60 days old, were exposed to Cre induction by tamoxifen to
knockout the Tmem16a gene. Briefly, mice were subjected, once
every 24 h for a total of 5 consecutive days, to intraperitoneal
injection of 100 µL of a 20 mg/ml tamoxifen solution in corn
oil. Twenty-four hours following the final injection, mice were
returned to their normal animal room, and closely monitored
for additional 55 days. The experimental procedures were
performed on male mice. The animal studies were carried out
in accordance with the approved guidelines; and were reviewed
and approved by the licensing and ethical committee of IRCCS
San Martino–IST and by the Italian Ministry of Health. All
animals were maintained in the C57Bl6/J strain for at least 20
generations. The RedMUC298trTg mice (Birchenough et al., 2016)
on C57Bl/6N background were housed and bred at the SPF unit
of the animal facility at the University of Gothenburg. All animal
experimental procedures were in full compliance according to
Swedish animal welfare and legislation and approved by the
Swedish Laboratory Animal Ethical Committee in Gothenburg,
Sweden (number 73-15).
mRNA Isolation and cDNA Synthesis
Wild type mice were killed through cervical dislocation and
intestinal tissues were immediately extracted, epithelium and
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smooth muscles from colon and ileum samples were isolated
by blunt dissection and homogenized in 500 µl of Trizol
(InvitrogenTM, TRIzolTM Reagent). To fragment high-molecular
weight cellular components (DNA) and to minimize their
presence in the aqueous phase, the tissue was passed 10
times through a sterile needle. For complete dissociation of
nucleoprotein complexes, the homogenate was incubated at RT
(15–25◦C) for 5 min and centrifuged at 12000× g during 10 min
at 4◦C. For subsequent phase separation, the supernatant was
collected and 100 µl of chloroform added. The sample was
vortexed vigorously for 15 s and incubated at RT (15–25◦C) for
3 min followed by centrifugation at 12,000 × g for 15 min at
4◦C. The aqueous phase was transferred to new 1.5 ml RNase-free
tube. To precipitate the RNA 250 µl of Isopropanol was added to
the samples and it was incubated at –20◦C overnight. Precipitated
RNA was centrifuged at 12,000 × g and purified byb adding
500 µl of 75% ethanol, following with centrifugation at 7,500× g
at 5 min at 4◦C. The dried pellet was resuspended with 35 µl
of nuclease free water, and stored at –80◦C. DNA contamination
was avoided using DNase treatment. Concentration and integrity
of the RNA were determined by spectrophotometry. Total RNA
was reverse transcribed into cDNA using the Superscript III
RTPCR System (Invitrogen) according to the manufacturer’s
recommendations. cDNA synthesis was performed on 2 µg RNA,
at 70◦C. cDNA integrity was checked using specific primers
to cyclophilin (Table 1). 50 ng template cDNA was added to
the reaction mixture. Cyclophilin amplification was performed
starting with a 5 min template denaturation step at 95◦C,
followed by 30 cycles of denaturation at 95◦C for 30 s and
combined primer annealing/extension at 55◦C. Relative intensity
of brightness of ethidium bromide-stained bands resolved on a
1.5% agarose gel was evaluated.
Real Time PCR
Quantification of Tmem16a, Cftr, and Cyclophilin
mRNA expression was performed using SYBR Green
detection in a LightCycler PCR machine according to the
manufacturer’s instructions.
We determined the PCR efficiency of each individual assay
by measuring serial of 100 ng cDNA from a pool of ileum
or colon from epithelia or smooth muscle in triplicate. Only
CT values < 40 were used for calculation of the PCR
efficiency. All PCRs displayed an efficiency between 96 and
100%. Amplifications were performed starting with a 3 min
template denaturation step at 94◦C, followed by 45 cycles
of denaturation at 94◦C for 20 s and combined primer
annealing/extension at the gene specific primer temperature for
30 s (Table 1). All samples were amplified in triplicate and
the mean was obtained for further calculations. Relative-fold
changes in target gene expression were quantified by the
previously reported 11CT method (Livak and Schmittgen,
2001). Briefly, epithelial and smooth muscle samples were
amplified in the same run. CT values were obtained for
individual samples using the Rotor-Gene 6000 software 1.7
(Corbett Life Science Pty Ltd., Sydney, Australia), where the
targets (Tmem16a or Cftr) and reference (Cyclophilin) had the
same cDNA concentration. 1CT was calculated by subtracting
the CT (target – reference).
Preparation of Epithelial Cells
Freshly collected distal colonic or distal small intestinal
tissue from wild type and RedMUC298trTg mice was flushed
with ice-cold HBSSwo (Hank’s balanced salt solution without
Mg2+/Ca2+ supplemented with 10 mM HEPES, pH 7.2)
to remove luminal content. The colonic tissue was inverted
and inflated by injection of HBSSwo. Epithelial isolation was
performed twice by incubation of tissue for 30 min in 20 ml
pre-digestion buffer (HBSSwo, 5 mM EDTA, 5% v/v FCS,
1 mM DTT) at 37◦C and 140 RPM. The epithelium was
detached by vortexing for 30 s and the remaining tissue was
discarded. The isolated epithelial cells were centrifuged at 400
RCF for 10 min at 4◦C, resuspended in 2 ml digestion buffer
(HBSS with Mg2+/Ca2+ supplemented with 2 mg/ml collagenase
type I and 40 U/ml DNase I) and incubated at 37◦C for
30 min, with mixing every 10 min. Cells were washed and
re-suspended in 1 ml ice-cold PBS. Cells were stained with
Fixable Viability Dye eFluorTM 780 (eBioscienceTM, 1:1000)
for 30 min, on ice and washed in 25 ml ice-cold HBSSwo
before re-suspension in 1 ml FACS buffer (HBSSwo, 2% v/v
FCS, 5 mM EDTA) prior to FACS. Goblet cells and remaining
epithelial cells were sorted using a FACS Jazz (Becton Dickinson)
according to the presence or absence of mCherry signal. Dead
cells were excluded from the sorting using the Fixable Viability
Dye eFluorTM 780. In the living population, discrimination
of doublets or aggregated cells was consecutively made for
SSC (SSC-Width (W)/ SSC-Height (H) plot) and for FSC
(FSC-W/FSC-H plot). The purity of the sorted cells was >96%
(See Supplemental Figure 1).
TABLE 1 | Primer sequences and annealing temperatures for the results presented in Figures 1A,B and 2A.
Gene Accession number Primer Sequence 5′–3′ Annealing
Temp. (◦C)
Cftr NM_021050.2 Forward: GCCATTTACCTTGGCATAGGC
Reverse: GCCAAGGCAAGTCCTTCATCA
63
Tmem16a NM_178642.5 Forward: AGGAATATGAGGGCAACCTG
Reverse: CGACACCATGGATTTTGGTA
63
Cyclophilin (Ppia) NM_008907.2 Forward: GGCAAATGCTGGACCAAACACAA
Reverse: GTAAAATGCCCGCAAGTCAAAAG
63
Tmem16a (Exons 6–16) NM_178642.5 Forward: AAGAGAACAACGTGCACCAA
Reverse: GAAATAGGCTGGGAATCGGT
61.3
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RNA Extraction and Sequencing
Sorted cells were pelleted at 400 RCF for 5 min and immediately
resuspended in 350 µl RLT buffer (Qiagen) supplemented with
β-merchaptoethanol (Gibco). Samples were homogenized using
QIAshredder columns (Qiagen) according to manufacturer’s
instructions. Goblet cell lysates were loaded onto RNeasy
MinElute column (Qiagen) and remaining epithelial cell lysates
onto RNeasy Mini column (Qiagen). The columns were washed
according to manufacturer’s instructions and RNA was eluted
with 35 µl (remaining epithelium) or 18 µl (goblet cells)
RNAse free H2O (Qiagen). The quality of isolated RNA
was determined using an Experion Automated Electrophoresis
platform (Bio-Rad) and samples were kept at –80◦C until
further analysis.
RNA sequencing was performed by the Genomics Core
Facility at the Sahlgrenska Academy (Gothenburg, Sweden).
cDNA libraries were prepared with TruSeq Stranded Total RNA
Sample Preparation kit with Ribo Zero Gold (Rev. E; Illumina)
according to manufacturer’s protocol and sequenced via paired-
end sequencing with the NextSeq500 platform (Illumina). The
quality for the sequencing was measured for all lanes, reads and
cycles with 93.4% of bases above Q30. Quality of the raw data
was assessed with the FastQC software (version 0.11.2) looking
at per base sequence quality and adapter contamination. The
reads were mapped using mouse reference genome mm10 using
aligner STAR (version 2.5.2b) and the number of the mapped
reads on each gene was calculated by the HTseq software (version
0.6.1p1). Normalization of the data and differential expression
were performed using the R package DESeq2 (version 1.14).
Peptide Preparation and LC-MS/MS
FACS sorted cells were solubilized in 30 µL lysis buffer (4% SDS,
100 mM Tris–HCl pH8, 100 mM DTT), heated 5 min at 95◦C
and digested with LysC and trypsin on 30 kDa filters (Vivacon
500, Sartorious Biotech) according to FASP protocol (Wiśniewski
et al., 2009b). Samples were pooled and fractioned according to
the pipette tip SAX protocol (Wiśniewski et al., 2009a) at pH 11,
8, 6, 5, 4 and 3. The remaining peptides were eluted in 50% ACN,
0.5% FA, 0.25 M NaCl. All samples were cleaned up with C18
StageTips (Rappsilber et al., 2007).
Peptides were analyzed with an EASY-nLC 1000 system
(Thermo Fisher Scientific) connected to a Q-Exactive
mass-spectrometer (Thermo Fisher Scientific) through a
nanoelectrospray ion source. SAX fractionated peptides were
analyzed with a reverse-phase column (150 mm × 0.075 mm
inner diameter, New Objective, Woburn, MA) packed in-house
with Reprosil-Pur C18-AQ 3 µm particles (Dr. Maisch,
Ammerbuch, Germany), using 120 min gradient, 0–25% B for
SAX pH 11 fraction, 5–40% B for SAX fractions pH 8, 6, 5, 4,
and 3, 5–60% B for final elution of SAX columns (A: 0.1% formic
acid, B: 0.1% formic acid/80% acetonitrile).
Q-Exactive was operated at 250◦C capillary temperature and
2.0 kV spray voltage. Full mass spectra were acquired in the
Orbitrap mass analyzer over a mass range from m/z 400 to 1600
with resolution of 70 000 (m/z 200). Twelve most intense peaks
with a charge state ≥2 were fragmented in the HCD collision
cell with normalized collision energy of 30%, and tandem mass
spectrum was acquired in the Orbitrap mass analyzer with
resolution of 17 500. Dynamic exclusion was set to 10 s. The
maximum allowed ion accumulation times were 60 ms for full
MS scans and 64 ms for tandem mass spectrum and AGC targets
5e5 for both, full MS and tandem MS.
MS raw files were processed with MaxQuant software
version 1.5.7.4 (Cox and Mann, 2008) by searching against
mouse UniProt database (canonical database, downloaded
20180611, containing 53 444 proteins). Searches were performed
with full tryptic specificity, maximum 2 missed cleavages,
carbamidomethylation of cysteine was set as a variable
modification, methionine oxidation and protein N-terminal
acetylation were set as variable modifications. False discovery
rate (FDR) was set to 1% both, for peptide and protein levels and
the minimum required peptide length was set to 6 amino acids.
Quantification was done based on LFQ protocol included in the
MaxQuant search.
Immunoblotting
Smooth muscle and epithelial samples of ileum and proximal
colon obtained from wild type and Tmem16fl/fl/Villincre/−
animals were obtained by blunt dissection and resuspended in
200 µl of RIPA buffer 1× (50 mM Tris–HCl pH 7.4, 150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
1 mM Na3VO4, 1 mM PMSF) containing Complete Protease
Inhibitor Cocktail. Tissue was homogenized using sonication
and then centrifuged at 16,000 × g for 30 min at 4◦C. Protein
concentration for each individual sample was determined using
the Pierce BCA protein quantification kit (Thermo Fisher
Scientific, Waltham, MA). Samples were electrophoresed (30 µg
per lane) with Tris–Glycine 4–20% gel and transferred to a
nitrocellulose membrane (Bio-Rad, Hercules, CA, United States)
for Western blotting. Nitrocellulose membranes were cut in
two pieces using the 75 kDa standard ladder as reference,
and both pieces were blocked with 5% BSA in Tris-buffered
saline including 0.1% Tween 20 (TBST) for 1 h at room
temperature. The upper membranes were incubated overnight
with TMEM16A primary antibody 1:1000 dilution (Abcam Cat#
ab64085, RRID:AB_1143505) or a rabbit polyclonal antibody
for TMEM16A raised against the N-terminus of mouse protein
(RVPEKYSTLPAEDR) as described previously (Huang et al.,
2009). After washing three times with TBST, the blots were
further incubated for 60 min at room temperature with an
anti-rabbit secondary antibody (1:20000 dilution Santa Cruz
Biotechnology, CA). In parallel the lower membranes were
incubated for 40 min with β-actin antibody (C-4) HRP (1:8000
dilution, Santa Cruz Biotechnology Cat# sc-47778 HRP, RRID:
AB_2714189). Both membranes were washed three times with
TBST and then visualized using the ECL (SuperSignal West
Femto Maximum Sensitivity Substrate, Thermo Fisher Scientific).
Immunolocalization of TMEM16A and
MUC-2
Histological sections of mouse intestine were deparaffinized
and subjected to antigen retrieval with 0.5% SDS in PBS
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for 15 min. After permeabilization with 0.3% Triton X-100
in PBS for 5 min, samples were blocked with 1% bovine
serum albumin (BSA) in PBS for 2 h and then incubated
overnight at 4◦C with an anti-TMEM16A antibody (Santa Cruz
Biotechnology Cat# sc-69343, RRID:AB_2058312) diluted 1:50 in
PBS containing BSA 1%.
Following incubation with primary antibody, tissues were
rinsed three times in PBS and incubated with goat anti-rabbit
Alexa Fluor 488 secondary antibody (Life Technologies)
diluted at 1:200 in 1% PBS-BSA for 1 h protected from the
light. After further 3 washes in PBS, slides were mounted
with Fluoroshield with 4′,6-diamidino-2-phenylindole (DAPI)
(Sigma-Aldrich) to stain cell nuclei. Confocal microscopy was
performed using a laser scanning confocal microscope TCS
SPE (Leica Microsystems). Image analysis was performed using
Leica and ImageJ software. Immunlocalization of TMEM16A
in human tissues was performed using the SP31 antibody
1:200 dilution. To detect bound antibodies, we used the LSAB
Universal Kit (Dako). The positive reaction was developed
with diaminobenzidine (Vector Labs) and sections were
counterstained with hematoxylin. The protocols to isolate,
culture, store, and study tissues from patients were approved
by the Regional Ethical Committee (Comitato Etico Regionale)
under the supervision of the Italian Ministry of Health
(registration number: ANTECER, 042-09/07/2018). Informed
and written informed consent was obtained using a form that
was also approved by the same Ethical Committee.
Intestinal sections were fixed in freshly prepared, ice-cold
Methacarn (methanol-Carnoy) solution (60% absolute methanol,
30% chloroform, 10% glacial acetic acid), Tissues were
washed in dry methanol (2 × 30 min), absolute ethanol
(2 × 15 min), absolute ethanol/ xylene 1:1 (1 × 15 min) and
in xylene (2 × 15 min), then waxed, paraffin embedded with
vertical orientation and cut in 4 µm thick sections. Paraffin
embedded sections were dewaxed with Xylene substitute and
rehydrated before antigen retrieval with 10 mM citric acid, pH6.
Immunostaining was performed with rabbit anti-MUC2-C3
(1:1000) (Johansson et al., 2008) or anti-Muc2 apomucin (PH
497) (1:1000) (Hansson et al., 1994). The staining was detected
with goat anti-rabbit IgG conjugated to Alexa Fluor R© 488
(Molecular Probes R©, Thermo Fisher Scientific, 1:2000). DNA
counter staining was carried out for 5 min using 1 µg/ml Hoechst
34580 (Molecular Probes R©, Thermo Fisher Scientific). Pictures
were obtained by using a Nikon eclipse E1000 fluorescence
microscope (Nikon) with 40×/0.75 or 20×/0.5 Plan Fluor
objectives. Images (2–3 sections analyzed per animal) were
acquired using the NIS elements software (Nikon). Samples were
shipped from the Chilean lab to the Swedish lab and genotypes
disclosed after staining and analysis.
Ussing Chamber Measurements
Stripped colon samples and intact ileum samples were placed in
0.1 cm2 surface area tissue-holders in modified Ussing chambers
(Physiologic Instruments, United States). Tissues were bathed
in bicarbonate-buffered solution (pH 7.4) of the following
composition (in mM): 120 NaCl, 25 NaCO3, 3.3 KH2PO4, 0.8
K2HPO4, 1.2 MgCl2, 1.2 CaCl2 and 10 D-glucose gassed with
5%CO2+95%O2 and kept through the experiment at 37◦C. The
transepithelial potential difference referenced to the basolateral
side was measured using a VCC MC2 amplifier (Physiologic
Instruments, United States) under current clamp mode. Short
200 ms 10 µA pulses were given every 1 s. The short-circuit
currents were calculated using the Ohm’s law as previously
described. After 10–15 min of incubation the tissues were
stimulated with either 100 µM carbachol (CCh) or 100 µM
ATP added on the basolateral side to induce calcium-activated
anionic secretion. The magnitude (1Isc) of the currents was
calculated as the difference after and before stimulation as
described (Flores et al., 2010).
Statistical Analysis
Unless otherwise stated all values corresponds to mean ± SEM.
All data were analyzed using Sigmaplot 12.3 software. The tests
used are described on each figure legend or in the main text
when corresponds.
RESULTS
Tmem16a Transcripts but Not Protein Is
Detectable in Mouse Intestinal
Epithelium
To analyze the expression of TMEM16A on intestinal tissues
we started determining mRNA levels in epithelial and smooth
muscle tissue samples. We reasoned that the smooth muscle
was a good control since it is known to express functional
TMEM16A channels (Huang et al., 2009), this tissue section
also includes Cajal cells with demonstrated high functional
expression of TMEM16A (Gomez-Pinilla et al., 2009; Sanders
et al., 2012). Interestingly, only proximal colon epithelium
showed significantly larger mRNA expression than its smooth
muscle counterpart (Figure 1A). When epithelial samples
were compared, proximal colon expressed a larger amount of
Tmem16a transcripts compared to ileum. Levels of Cftr mRNA
were also determined and showed to be significantly higher
in both ileum and colon epithelium when compared to the
corresponding smooth muscle layer (Figure 1B).
It has been shown that goblet cells express calcium-activated
anion channels in colon (Yu et al., 2010) and airway (Scudieri
et al., 2012) goblet cells. So, a more detailed analysis of
Tmem16a and Cftr mRNA expression was performed in goblet
and enterocytes (non-goblet) isolated from intestinal epithelium.
As observed in Figure 1C, Tmem16a was almost absent in
ileum but significantly higher in distal colon (p < 0.001 one
way ANOVA), and in the case of colon, more abundant on
enterocytes than goblet cells (Figure 1C). Expression of Cftr
mRNA was detected in both ileum and distal colon epithelial
and goblet cells with similar variation between the groups as
seen for Tmem16a expression (Figure 1D). Finally, analysis of
the proteome detected very low levels of TMEM16A in ileum,
but showed significantly higher expression of TMEM16A in
distal colon, a level that still could be considered a low when
compared to other proteins like the triple-cotransporter NKCC1
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FIGURE 1 | (A) Cftr and (B) Tmem16a transcripts isolated from epithelium (E, blue circles) or muscle (SM, red circles) of ileum and proximal colon; Values
correspond to 2−11CT Tmem16a (A) or Cftr (B), normalized to Cyclophilin and relative to epithelium; n = 4–5 for each group and p indicates the corresponding
t-test value. (C) Tmem16a expression from RNAseq analysis of sorted goblet (GC, red circles) and non-goblet cells (NGC, blue circles) in ileum and distal colon;
n = 4 per group. (D) Cftr expression from RNAseq analysis of sorted goblet (GC, red circles) and non-goblet cells (NGC, blue circles) in ileum and distal colon; n = 4
per group. (E) Abundance of TMEM16A protein by proteomics using label free quantification of sorted goblet (CG, red circles) and non-goblet cells (NGC, blue
circles) in ileum and distal colon n = 2–4 per group.
(4.2e+8 ± 8e+7 and 3.5e+8 ± 3e+7 LQF; n = 4 for both
data sets) in goblet cells from ileum and colon, respectively. In
summary, we found a higher expression of mRNA and protein
for TMEM16A in colon than ileum in mouse.
Next we used the intestinal-specific Tmem16-null animals
(Tmem16fl/fl/Villincre/−) to test TMEM16A expression. To
confirm the specific deletion of exon 12 from the Tmem16a
gene, mRNA isolated from epithelium and smooth muscle was
retro-transcribed and screened by PCR with primers harboring
exons 6 to 16 of the gene. Wild type Ileum presented a PCR
product of ∼800 bp. After deletion of exon 12 (83 bp) a band
between 700 and 750 bp was noticeable. Mouse proximal colon
was rich in a ∼750–800 bp PCR product that was not present in
the Tmem16fl/fl/Villincre/− animals and a ∼650 bp band appears
instead. A ∼700 bp PCR product was amplified from muscle in
ileum and proximal colon and found to remain unaltered in the
Tmem16fl/fl/Villincre/− mouse (Figure 2A).
Finally, immunoblot detection of TMEM16A protein was
performed with 2 different antibodies. On both occasions we
observed nearly non-detectable protein in epithelial samples
from ileum and proximal colon, while smooth muscle showed a
constant detectable amount of TMEM16A protein in all samples
(Figures 2B,C). The double band observed with both antibodies
has also been detected by others when using different antibodies
(Yu et al., 2010; Mroz and Keely, 2012; Rottgen et al., 2018). This
might account for the diversity of TMEM16A variants expressed
in intestinal tissues (O’Driscoll et al., 2011).
To further explore intestinal TMEM16A expression we
attempted immunofluorescence detection on intestinal tissues.
Positive staining was observed in the cytoplasm and few cells
stained with apical membrane in both ileum and proximal colon
of the wild type animals. Nevertheless, similar staining was
observed in the Tmem16afl/fl/Villincre/− samples (Supplemental
Figures 2A–D). These results indicate that the antibody used
for the staining cannot correctly recognize the murine protein
in the intestine. Finally, we immuno-localized TMEM16A in
human tissue samples, and positive reaction was found in
cells that resemble those of interstitial Cajal cells but no
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FIGURE 2 | TMEM16A is not expressed in intestinal epithelium in mouse. (A) cDNA screening for exon 12 deletion after recombinase activity in the
Tmem16afl/fl/Villincre/− mouse. Representative image of 3 analyzed animals per group. (B,C) TMEM16A protein expression in intestine was tested in smooth muscle
and epithelium of ileum (I) and proximal colon (C) of wild type and Tmem16afl/fl/Villincre/− animals. Expected molecular weight for TMEM16 is 114 kDa and 42 for
β-actin. Representative image of 3 experiments.
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staining was observed on the epithelial layer (Supplemental
Figures 2E,F).
TMEM16A Does Not Participate in Anion
Secretion of the Mouse Intestine
To test if TMEM16A participates in the electrogenic
anion secretion of the intestine, we performed Ussing
chamber experiments on ileum and proximal colon
samples of mice including Cftrfl/fl/Villincre/−, and
Cftrfl/fl/Tmem16afl/fl/Villincre/− double mutants. Even though,
we did not find any differences in carbachol (CCh) activated
anion secretion between proximal and distal colon (50.9 ± 4 vs.
58.3± 9 µA cm−2, respectively; n = 3 per group; p > 0.05 t-test),
we chose to work with proximal colon as it has been previously
shown to present stronger responses to calcium agonists
(Schreiber et al., 2015). As shown in Figure 3, CCh stimulation
induced a rapid change in Isc interpreted as anionic secretion
in ileum (Figure 3A) and proximal colon (Figure 3B) of wild
type animals. Silencing of Tmem16a did not affect CCh-response
in any of the tissues. Nevertheless, intestinal silencing of the
Cftr gene almost ablated the CCh response of the intestinal
epithelium. Interestingly, the double mutant tissues showed
similar responses as the Cftrfl/fl/Villincre/− intestine discarding a
further effect of TMEM16A on intestinal anion secretion.
To discard the possibility that carbachol signaling is
uncoupled from TMEM16A activation in the intestine, we tested
the effect of a different calcium agonist. We chose ATP that
is known to activate TMEM16A (Namkung et al., 2011b), and
observed that ATP-induced anion secretion was not affected by
Tmem16a silencing in proximal colon (Figure 3C). The CCh and
ATP experiments are summarized in Figures 3D,E, respectively.
Lack of CFTR but Not TMEM16A Results
in Mucus Disruption and Bacterial
Accumulation in Mouse Intestine
Mucus homeostasis is tightly related to anion secretion in the
intestine (Gustafsson et al., 2012). To test if TMEM16A deficiency
affects mucus homeostasis we performed Muc2 mucin staining
on fixed intestinal tissues. As observed in Figure 4A mature
Muc2 was massively released from the crypts and the mucus layer
was unstructured in Cftrfl/fl/Villincre/−. The same pattern was
observed in samples obtained from the Cftr1F508/1F508 mouse
(Supplemental Figure 3A), confirming that Cftr silencing in
intestinal epithelium is sufficient to cause the mucus alterations.
The insets shown in Figure 4B show that mucus organizes
in outer and inner layers, but such organization is lost when
Cftr is silenced. We next analyzed colon samples from the
Tmem16afl/fl/Villincre/− animals and found no changes in mucin
appearance compared to wild types, but the analysis of the double
mutant tissues showed similar mucus alterations as observed in
Cftrfl/fl/Villincre/− mouse (Figure 4A). Control staining in the
colon of Villincre/− animals showed no alterations in their mucus
structure (Supplemental Figure 3A).
A similar pattern of alterations was observed in ileum samples
stained for mature Muc2. After Cftr silencing Muc2 accumulates
in the crypts and between villi (Supplemental Figure 3B).
This was not the case when Tmem16a was silenced, as
there are no detectable differences in the staining of mature
Muc2 when compared to wild type tissues. Samples obtained
from the double mutant animals showed the same features
as the Cftrfl/fl/Villincre/− animals. Additional analysis of
immature Muc2 (Muc2-apomucin) staining, normally located
in the intracellular compartment, showed no extracellular
accumulation after Cftr and/or Tmem16a silencing in colon and
ileum (Supplemental Figure 4).
Another common phenomenon that affects CF mice and
patients is the overgrowth of bacteria in the intestine (Norkina
et al., 2004; Dorsey and Gonska, 2017). Using DNA staining we
observed that samples from the colon of Cftrfl/fl/Villincre/− and
double mutant animals showed increased amount of bacteria
in the inner mucus layer, close to the apical membrane of the
epithelium when compared to the wild type samples (Figure 4C).
In most samples we did not observe bacteria in direct contact with
the epithelium or in the mucus of the colon crypts. The samples
from Tmem16afl/fl/Villincre/− animals had a stratified mucus
separating bacteria from the epithelium as seen in wild type mice.
Tmem16a Intestinal Deletion Did Not
Affect Survival in the Cftrfl/fl/Villincre/−
Mouse
We observed that Tmem16a deletion from intestinal epithelium
did not alter survival determined up to 60 days of age. In order
to evaluate if Tmem16a could act as a modifier and might
enhance lethality in a model that is already affected by intestinal
obstructive disease like the Cftrfl/fl/Villincre/− mouse. To test this
possibility, we recorded survival for the double mutant mice. Our
results demonstrate that there are no changes in lethality between
the double mutant and Cftrfl/fl/Villincre/− animals (Figure 5A),
discarding a role for TMEM16A in causing lethal intestinal
obstruction. Dead mice carcasses that could be recovered for
post-mortem examination showed rupture of the small intestine.
We studied also the lethality of inducible Tmem16a-null mice
and found that the phenotype is 100% lethal in adult mice,
demonstrating that lethality after Tmem16a silencing is due to a
severe non-intestinal phenotype.
Finally, we recorded weight of animals at 58–60 days and
found that intestinal silencing of Cftr produced a body weight
reduction independently of Tmem16a silencing (Table 2).
DISCUSSION
Calcium-activated anion secretion has been postulated as an
alternative to CFTR, with important therapeutic implications
in cystic fibrosis. The advent of the use of animal models
to study CF was marked by the observation that mouse
models were severely affected by intestinal and not lung disease
(Guilbault et al., 2007). Shortly after generation of the first
CF mice (generated by Cftr gene knockout or insertion of
CF-causing mutations), studies demonstrated that the surviving
animals displayed calcium-activated anion currents in diverse
tissues including the intestine. This anion conductance was
hypothesized to be responsible for a mild CF phenotype and
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FIGURE 3 | Cftr but not Tmem16a silencing abolished calcium-activated anion secretion in mouse intestine. Representative images of CCh-induced short-circuit
currents (Isc) from in the ileum (A) and proximal colon (B) of the different mice. (C) Representative images of ATP-induced short-circuit currents in the wild type and
Tmem16afl/fl/Villincre/− mice. Red arrowheads indicate the time of CCh (100 µM) or ATP (100 µM) addition on the basolateral side for each image. Short-circuit
current changes (1Isc) in ileum and colon induced by CCh (D), and in colon induced by ATP (E), are summarized; n = 4–6 for CCh in ileum and colon on each group;
n = 5 for wild type and n = 4 for Tmem16afl/fl/Villincre/− in the ATP experiments. Indicated p values correspond to one way ANOVA (D) or unpaired t-test (E) analysis.
No significant difference found for groups in panel (E).
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FIGURE 4 | Mucus homeostasis and bacterial accumulation is not affected by Tmem16a silencing in the proximal colon of mouse. (A) Representative images of
Muc2 staining (green) in Carnoy’s fixed colon samples. Red arrows indicate massive release of mucus from the crypts and white arrows indicate poorly structured
mucus layer. Blue staining corresponds to Hoescht nuclear DNA. White asterisks indicate crypts that are amplified in panel (B). (B) Images show detailed mucus
structured in clearly defined external layer (red arrow head) and internal layer (white arrow head). Layers remain conserved in the Tmem16afl/fl/Villincre/− tissues, but
organization is lost when Cftr is silenced. (C) Cftr silencing shows the presence of bacteria accumulation independently of Tmem16a expression. Some bacteria can
be seen invading the mucus layers; n = 5 animals for each group and 2–3 fields were analyzed for each animal.
enhanced survival (Clarke et al., 1994; Rozmahel et al., 1996;
Wilschanski et al., 1996). Similar observations were also reported
in humans, unleashing the hunt for calcium-activated anion
channels parallel to CFTR (Veeze et al., 1994). As several genes
were proposed to encode the elusive calcium-activated chloride
channel it was not until 2008 that TMEM16A was identified as
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FIGURE 5 | Intestinal silencing of Tmem16a is not lethal in the mice. (A) Kaplan–Meier curves showing survival of the Tmem16afl/fl/Villincre/−, Cftrfl/fl/Villincre/− and
Tmem16afl/fl/Villincre/− double mutant mice. Intestinal silencing of Tmem16a does not alter survival of the Cftrfl/fl/Villincre/− mouse. Log-Rank test: ∗ indicates
p = 0.025 and ∗∗p = 0.028. (B) Tmem16a tamoxifen (Tam) inducible silencing produced a lethal phenotype in mice. Arrows indicate the last dose of tamoxifen in
both groups. Log-Rank test: ∗ indicates p < 0.001.
TABLE 2 | Mice weight is affected after Cftr but not Tmem16a silencing in mouse intestine.




Wild type 22.6 ± 0.7 7 – p = 0.04∗ p = 0.324
Cftrfl/fl/Villincre/− 19.0 ± 2.1 6 p = 0.04∗ – p = 0.003∗
Tmem16afl/fl/Villincre/− 24.7 ± 1.5 6 p = 0.324 p = 0.003∗ –
Double mutant 13.5 ± 1.0 6 p < 0.001∗ p = 0.008∗ p < 0.001∗
Analysis of weight in 58–60 days old mice; p values correspond to results after Two-way ANOVA.
the protein responsible for calcium-activated chloride secretion
(Caputo et al., 2008; Schroeder et al., 2008; Yang et al., 2008).
The first attempt to test the role of TMEM16A in the
intestinal secretory function was performed in the systemic
Tmem16a−/− mice. Due to the severe lethal phenotype, causing
death of animals in the first days of life, the experiments were
performed in distal colon of pups. In this way it was possible
to observe an almost completely absence of carbachol-induced
chloride secretion, but no reduction in cAMP-induced chloride
secretion indicating that the two ion conductive pathways
were occurring through different channels (Ousingsawat et al.,
2009). Intriguingly, we observed that the Tmem16a gene is
transcribed in colon epithelium but we were unable to find
convincing TMEM16A protein expression using three different
antibodies in the mouse (Figures 1A–D) and a fourth in
human intestine (Supplemental Figures 2E–F). Several other
reports are in accordance with our observations. In one of the
earliest efforts to identify the TMEM16A channel in mouse
tissues the protein was not detected in intestinal epithelial cells
(Huang et al., 2009), and during the identification of interstitial
cells of Cajal in human and mouse intestine, TMEM16A was
rarely seen in cells of the mucosa, and when found the
morphology and location of positive cells corresponded to
myofibroblasts and not to epithelial cells (Gomez-Pinilla et al.,
2009). In large scale screenings of human tumors, TMEM16A
expression was consistently present in gastrointestinal cancers
and also in several normal tissues including epithelium of breast,
prostate, salivary glands, stomach, pancreas and gallbladder,
but not in small or large intestine epithelium (West et al.,
2004; Miettinen et al., 2009). TMEM16A expression in human
gastrointestinal tumors might also explain the reported activity
of TMEM16A on immortalized human intestinal cells (Namkung
et al., 2011a; Mroz and Keely, 2012). Moreover, upregulation
of the channel expression has been related with increased
metastasis in human colorectal tumor cells (Sui et al., 2014),
suggesting that TMEM16A expression on the intestine is part
of the pathophysiology of intestinal tumorigenesis. Nevertheless,
is necessary to point out that other studies show epithelial
cell with TMEM16A staining in some cases using the same
antibodies tested by ourselves (Yu et al., 2010; He et al., 2011;
Ousingsawat et al., 2011; Benedetto et al., 2017; Rottgen et al.,
2018). In addition we analyzed the protein content of goblet
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and non-goblet cells prepared from the intestinal epithelium
and we do not find any TMEM16A in the small intestine but
detected peptides at a low level in distal colon suggesting a
low expression not detectable using immunohistochemistry or
western blot (Figure 1E).
Due to discrepancies in the literature regarding the existence
of a calcium-activated anion channel in the intestine that
most likely corresponds to TMEM16A and the inherent
limitation of the use of antibodies, we aimed to study this
issue performing functional experimental approaches to try
to understand the participation of TMEM16A on intestinal
physiology. We included the breeding of an intestinal double
knock-out mouse that lacks Cftr expression to test the role
of TMEM16A on the intestine. This was based on the fact
that intestinal Cftr silencing is sufficient to induce lethal
obstructive episodes whose origin is due to attached mucus
causing bacterial overgrowth (Hodges et al., 2008; Gustafsson
et al., 2012; Schutte et al., 2014). We reasoned that in this
altered intestinal environment the contribution of alternative
anion channels are highly relevant in maintaining the secretory
function after Cftr silencing. As expected, the intestinal
silencing of Cftr drastically reduced anion secretion in ileum
and proximal colon (Figure 3), that was accompanied with
altered mucus properties and attachment (Figure 4). Attached
mucus results in bacteria overgrowth and lethal intestinal
infections in a significant fraction of animals (Figure 5)
a phenomenon observed previously in this model (Hodges
et al., 2008; Philp et al., 2018). On the contrary, intestinal
silencing of Tmem16a had no effect on CCh or ATP induced
calcium mediated anion secretion in ileum or proximal colon
(Figure 3) and concomitantly did not affect mucus homeostasis
or induce lethality in the animals, discarding a role for
TMEM16A in epithelial anion secretion or bacterial overgrowth.
As observed also in Figure 5, we induced the whole-body
silencing of TMEM16A in the adult mouse using the tamoxifen
inducible recombinase expression, and found that animals
were lethally affected. This indicates that TMEM16A silencing
induce a severe lethal phenotype which is different to the
previously observed effects on airway development in the
Tmem16a−/− animal, and where intestinal TMEM16A unrelated
(Rock et al., 2008).
It has been recently published that TMEM16A is essential
for mucus secretion in the intestine and airways and that there
is a higher level of expression of the protein in goblet cells
(Benedetto et al., 2018). Our proteomic results show that the
TMEM16A protein was found in low amounts in both goblet
and non-goblet cells of the colon. We also observed that mucus
architecture in both inner and outer mucus layers are clearly
seen undisturbed in the Tmem16a deficient tissues but are
severely altered in the Cftrfl/fl/Villincre/− mouse (Figures 4A,B),
suggesting that TMEM16A is not required for normal mucus
homeostasis in colon.
Finally, we asked if the remaining anion secretion observed
in our intestinal Cftr-deficient animals was due to TMEM16A
activity. As previously discussed this anion transport pathway
is considered as a beneficial factor for the clinical course of
the disease and related to a decreased frequency of intestinal
obstructive episodes. As shown here in Figure 3, the silencing
of Tmem16a in a Cftrfl/fl/Villincre/− background did not alter
CCh or ATP-induced anion with respect to that observed in
the Cftrfl/fl/Villincre/− mutant mouse, suggesting that TMEM16A
does not participate in the remnant anion secretion seen in the
absence of CFTR. It has been demonstrated that the remaining
current in the colon of the Cftr−/− mouse corresponds to
bicarbonate secretion from goblet cells mediated by the activity of
Bestrophin-2 (Yu et al., 2010). In agreement with Yu et al. (2010)
observations, we detect a remaining current in the colon, but
not in the ileum of the Cftrfl/fl/Villincre/− animals (Figure 3D).
Although we have not tested cAMP involvement directly it is
known that cAMP-induced anion secretion is not affected by
Tmem16a silencing (Ousingsawat et al., 2009). More recently,
Benedetto et al. (2017) observed that after intestinal silencing
of Tmem16a there is a near total absence of cAMP and Ca2+
induced anion secretion. In addition, the same authors observe
that intestinal Tmem16a inactivation led to an irregular and
thinner mucus layer covering the colon epithelium (Benedetto
et al., 2018). In contrast to this finding, we do not observe
any changes in anion secretion and mucus layer organization
in agreement with the absence of weight loss and lethality in
these animals (Figure 5A). Surprisingly, there is no report of
lethal intestinal obstruction in the mice used by Benedetto et al.
(2017, 2018) as would have been expected from the severe
secretory deficiency and mucus accumulation they report. Their
contention that inhibition of TMEM16A might help to decrease
mucus release and thus overcome obstruction is not upheld by
the unaltered lethality we observe in our Cftrfl/fl/Villincre/− mice
after additional Tmem16a silencing (Figure 5A). Future studies
that allow the specific silencing of Tmem16a from goblet cells are
required to elucidate the present differences.
But what is that Tmem16a silencing decreases weight gain in
the Cftrfl/fl/Villincre/− mice? It might be possible that TMEM16A
is expressed in an exclusive and minor subset of epithelial
cells, explaining the TMEM16A positive signal found by the
proteomics, responsible of controlling subtle nutrient uptake but
unrelated to anion secretion. Since this “fail to thrive” phenotype
of TMEM16A is only evident after Cftr silencing, it suggests
that CFTR can replace TMEM16A in this function, but this
is not occurring the other way round. Another possibility is
that TMEM16A is expressed exclusively early after birth and
surmounted later by CFTR in the intestine of the mouse, while
in older animals housing conditions, microbiota or the genetic
background of the animals could have an impact on the transport
properties of the intestine and explain in part some of the
differences observed in intestinal TMEM16A function across
different publications (Flores et al., 2010).
Soon after its identification as the calcium-activated chloride
channel, TMEM16A became a “hot topic” in epithelial
physiology, particularly in airways and intestine. While its
role in airway epithelium was fast elucidated and still remains
unequivocally as a calcium-activated anion channel located
in the apical membrane and allowing chloride and possibly
bicarbonate secretion (Scudieri et al., 2012; Gorrieri et al., 2016),
its role in the intestine has been hampered by contradictory
results (Ousingsawat et al., 2009; Rock et al., 2009; He et al., 2011;
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Namkung et al., 2011a). While some of these inconsistencies
can be explained by the use of inhibitors that are not so
specific like niflumic acid that blocked calcium entry in the
cells (Balderas et al., 2012) or the CaCCinh-A01 inhibitor, a
molecule that also can block CFTR (Gianotti et al., 2016),
results using animal models are more difficult to reconcile. While
some evidence relates TMEM16A functioning as an apical anion
channel secreting chloride to the gut lumen in the same fashion
as it had been observed in the airways (Ousingsawat et al., 2009;
Rottgen et al., 2018), some evidence points toward a basolateral
localization where TMEM16A is regulating calcium-activated
chloride secretion indirectly through the maintenance of calcium
store release from the endoplasmic reticulum (He et al., 2011;
Benedetto et al., 2017). Our own exploration of TMEM16A
function on the intestine, carried out in different laboratories,
showed that TMEM16A do not participate in calcium-dependent
intestinal anion secretion or in intestinal mucus homeostasis.
There is still need for further studies of the role of TMEM16A
in intestinal epithelial function.
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